Copyright
        ©The Author(s) 2016.
    
    
        World J Gastroenterol. Sep 21, 2016; 22(35): 7882-7891
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7882
Published online Sep 21, 2016. doi: 10.3748/wjg.v22.i35.7882
		Figure 1 Application of biomarkers in ulcerative colitis surveillance protocol.
		
			 1Management of LGD is dependent on the clinician and patient choices. HGD: High-grade dysplasia; CRC: Colorectal cancer; LGD: Low-grade dysplasia.
		
	
- Citation: Chen R, Lai LA, Brentnall TA, Pan S. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol 2016; 22(35): 7882-7891
- URL: https://www.wjgnet.com/1007-9327/full/v22/i35/7882.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i35.7882

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                         
                        